Search

Your search keyword '"Han, Edward"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Han, Edward" Remove constraint Author: "Han, Edward" Database Unpaywall Remove constraint Database: Unpaywall
67 results on '"Han, Edward"'

Search Results

2. GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice

6. Supplementary Data from Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways

7. Supplementary Data from Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways

8. Data from Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways

13. List of Contributors

16. Development of a Bioartificial Vascular Pancreas

17. Chemical mutagenesis of a GPCR ligand: Detoxifying “inflammo-attraction” to direct therapeutic stem cell migration

22. Organ‐on‐a‐Chip: Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature‐on‐a‐Chip System Correlates with Tumor Heterogeneity and Subtypes (Adv. Sci. 8/2019)

25. Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature‐on‐a‐Chip System Correlates with Tumor Heterogeneity and Subtypes

26. Ex vivo dynamics of human glioblastoma cells in a microvasculature-on-a-chip system correlates with tumor heterogeneity and subtypes

28. Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition

31. ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

33. Abstract 2067: Attacking prostate cancer with a prodrug-doped cellular Trojan horse

35. A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer

38. A Small-Molecule Screen for Enhanced Homing of Systemically Infused Cells

40. Aminopyrimidinone Cdc7 Kinase Inhibitors

42. Abstract A161: Acquired resistance to combination treatment with TMZ and ABT‐888 is mediated by both BER and HR DNA repair pathways

43. Discovery of 3H-Benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM) Kinases

44. Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways

48. ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

49. Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitors

50. Optimal Classes of Chemotherapeutic Agents Sensitized by Specific Small-Molecule Inhibitors of Akt In Vitro and In Vivo

Catalog

Books, media, physical & digital resources